After targeted agents, a novel bispecific in EGFR-mutant lung cancer improves PFS.

Published Date: 03 Jun 2024

FDA approval could be hampered by a trial conducted in China, though.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A US health panel advises starting mammograms at age 40 rather than 50.

2.

Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer

3.

Cancer Deaths Fall, Cases Rise; Diabetes and Cancer Risk; Vitamin C for Cancer

4.

Spicy Chip Death Lawsuit; Gen X and Cancer; Extreme U.S. Temperatures

5.

Distribution of fat could influence cancer risk, study suggests


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot